ACT Pharmacy Collaborative Will Launch 3 New Signature Programs This Fall
Collaboration among faculty, students, national associations, and community pharmacy leaders is crucial as pharmacy practice continues to transform.
FDA Approves Sotagliflozin for Treatment of Heart Failure
New Treatment Approved for Menopausal Hot Flashes
Fezolinetant (Veozah) is approved for the treatment of moderate to severe vasomotor symptoms (ie, hot flashes and night sweats) related to menopause.
Topical Analgesics: A New Frontier for First-Line Pain Management
Despite a wealth of data proving their efficacy for acute and chronic pain, these products remain underutilized in the United States.
Inside Insomnia: Pharmacist Management of Sleep Disorders
Digging deeper into the cause of insomnia and counseling patients on lifestyle changes can help improve their sleep health.
Here’s a Tip: More Money Is the Solution
In many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.
2023-2024 Flu Season: What to Expect
As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.
Utilizing AI for Medication Management
Pharmacists can utilize AI for medication management and to prevent medication errors.
Pharmacists Applaud New Bionic Pancreas for Type 1 Diabetes
The iLet Bionic Pancreas combines data from the Dexcom G6 CGM with different algorithms to deliver insulin throughout the day.
Pharmacists Role in Opioid Stewardship, Perioperative Main Management Crucial
ASHP: Adalimumab Biosimilar Pipeline Review
At least 6 adalimumab biosimilars are set to launch in July 2023.
